Literature DB >> 9601104

The Polo-like kinase Plx1 is a component of the MPF amplification loop at the G2/M-phase transition of the cell cycle in Xenopus eggs.

A Abrieu1, T Brassac, S Galas, D Fisher, J C Labbé, M Dorée.   

Abstract

We have investigated whether Plx1, a kinase recently shown to phosphorylate cdc25c in vitro, is required for activation of cdc25c at the G2/M-phase transition of the cell cycle in Xenopus. Using immunodepletion or the mere addition of an antibody against the C terminus of Plx1, which suppressed its activation (not its activity) at G2/M, we show that Plx1 activity is required for activation of cyclin B-cdc2 kinase in both interphase egg extracts receiving recombinant cyclin B, and cycling extracts that spontaneously oscillate between interphase and mitosis. Furthermore, a positive feedback loop allows cyclin B-cdc2 kinase to activate Plx1 at the G2/M-phase transition. In contrast, activation of cyclin A-cdc2 kinase does not require Plx1 activity, and cyclin A-cdc2 kinase fails to activate Plx1 and its consequence, cdc25c activation in cycling extracts.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9601104     DOI: 10.1242/jcs.111.12.1751

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  65 in total

1.  The role of Plo1 kinase in mitotic commitment and septation in Schizosaccharomyces pombe.

Authors:  K Tanaka; J Petersen; F MacIver; D P Mulvihill; D M Glover; I M Hagan
Journal:  EMBO J       Date:  2001-03-15       Impact factor: 11.598

2.  A new genetic method for isolating functionally interacting genes: high plo1(+)-dependent mutants and their suppressors define genes in mitotic and septation pathways in fission yeast.

Authors:  C F Cullen; K M May; I M Hagan; D M Glover; H Ohkura
Journal:  Genetics       Date:  2000-08       Impact factor: 4.562

3.  A novel regulatory element determines the timing of Mos mRNA translation during Xenopus oocyte maturation.

Authors:  Amanda Charlesworth; John A Ridge; Leslie A King; Melanie C MacNicol; Angus M MacNicol
Journal:  EMBO J       Date:  2002-06-03       Impact factor: 11.598

4.  Initial activation of cyclin-B1-cdc2 kinase requires phosphorylation of cyclin B1.

Authors:  Marion Peter; Christian Le Peuch; Jean-Claude Labbé; April N Meyer; Daniel J Donoghue; Marcel Dorée
Journal:  EMBO Rep       Date:  2002-05-24       Impact factor: 8.807

5.  Schizosaccharomyces pombe NIMA-related kinase, Fin1, regulates spindle formation and an affinity of Polo for the SPB.

Authors:  Agnes Grallert; Iain M Hagan
Journal:  EMBO J       Date:  2002-06-17       Impact factor: 11.598

6.  Plk1 regulates activation of the anaphase promoting complex by phosphorylating and triggering SCFbetaTrCP-dependent destruction of the APC Inhibitor Emi1.

Authors:  David V Hansen; Alexander V Loktev; Kenneth H Ban; Peter K Jackson
Journal:  Mol Biol Cell       Date:  2004-10-06       Impact factor: 4.138

7.  Essential function of the polo box of Cdc5 in subcellular localization and induction of cytokinetic structures.

Authors:  S Song; T Z Grenfell; S Garfield; R L Erikson; K S Lee
Journal:  Mol Cell Biol       Date:  2000-01       Impact factor: 4.272

8.  Suppression of the Schizosaccharomyces pombe cut12.1 cell-cycle defect by mutations in cdc25 and genes involved in transcriptional and translational control.

Authors:  Victor A Tallada; Alan J Bridge; Patrick A Emery; Iain M Hagan
Journal:  Genetics       Date:  2007-04-03       Impact factor: 4.562

9.  Female infertility in PDE3A(-/-) mice: polo-like kinase 1 (Plk1) may be a target of protein kinase A (PKA) and involved in meiotic arrest of oocytes from PDE3A(-/-) mice.

Authors:  Weixing Shen; Faiyaz Ahmad; Steven Hockman; John Ma; Hitoshi Omi; Nalini Raghavachari; Vincent Manganiello
Journal:  Cell Cycle       Date:  2010-12-01       Impact factor: 4.534

10.  Xp38gamma/SAPK3 promotes meiotic G(2)/M transition in Xenopus oocytes and activates Cdc25C.

Authors:  Eusebio Perdiguero; Marie-Jeanne Pillaire; Jean-Francois Bodart; Florian Hennersdorf; Morten Frödin; Nicholas S Duesbery; Gema Alonso; Angel R Nebreda
Journal:  EMBO J       Date:  2003-11-03       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.